Policy # Policy Title Print View
VP-0001 Abraxane® (paclitaxel protein-bound particles) (Intravenous)
VP-0014 Avastin® (bevacizumab) (Intravenous)
VP-0130 Bendamustine (Treanda®; Bendeka™) (Intravenous)
VP-0137 Velcade® (bortezomib) (Intravenous/Subcutaneous)
VP-0148 Yervoy™ (ipilimumab) (Intravenous)
VP-0184 Gazyva (obinutuzumab) (Intravenous)
VP-0209 Keytruda® (pembrolizumab) (Intravenous)
VP-0225 Blincyto® (blinatumomab) (Intravenous)
VP-0226 Opdivo® (nivolumab) (Intravenous)
VP-0266 Darzalex™ (daratumumab) (Intravenous)
VP-0278 Tecentriq™ (atezolizumab) (Intravenous)
VP-0295 Bavencio® (avelumab) (Intravenous)
VP-0351 Bortezomib* (Intravenous Only)
VP-0422 Bendamustine (bendamustine ready-to-dilute) (Intravenous) (Belrapzo™)
VP-0461 Mvasi™ (bevacizumab-awwb) (Intravenous)